Recursion Pharmaceuticals, Inc. (RXRX)
NASDAQ: RXRX · Real-Time Price · USD
3.410
-0.070 (-2.01%)
At close: Apr 28, 2026, 4:00 PM EDT
3.400
-0.010 (-0.29%)
After-hours: Apr 28, 2026, 7:56 PM EDT
Recursion Pharmaceuticals Employees
Recursion Pharmaceuticals had 600 employees as of December 31, 2025. The number of employees decreased by 200 or -25.00% compared to the previous year.
Employees
600
Change (1Y)
-200
Growth (1Y)
-25.00%
Revenue / Employee
$124,468
Profits / Employee
-$1,074,598
Market Cap
1.80B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Galapagos NV | 558 |
| Vericel | 398 |
| Syndax Pharmaceuticals | 298 |
| Harmony Biosciences Holdings | 293 |
| Innoviva | 159 |
| Pharvaris | 129 |
| Inhibrx Biosciences | 110 |
| AnaptysBio | 104 |
RXRX News
- 15 days ago - Recursion Pharmaceuticals Transcript: 25th Annual Needham Virtual Healthcare Conference - Transcripts
- 21 days ago - Recursion to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - Recursion Expands Strategic Partnership with Citeline to Advance Its AI-Enabled ClinTech Platform - GlobeNewsWire
- 4 weeks ago - Recursion Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer - GlobeNewsWire
- 6 weeks ago - Recursion Pharmaceuticals Transcript: 2026 KeyBanc Capital Markets Healthcare Forum - Transcripts
- 7 weeks ago - Recursion Pharmaceuticals Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Recursion Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Recursion Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts